Open access · CC-BY
via OpenAlex
Interplay between hypoxia and inflammation in cancer progression, therapy resistance, and natural cancer resistance
Ageing and Cancer Research & Treatment · 2026
Abstract
The microenvironment of solid tumors is characterized by dynamic availability of oxygen and persistent, complex inflammatory signaling. Accumulating evidence suggests that hypoxia and inflammation actively influence tumor progression and therapeutic response. In physiological conditions, hypoxic and inflammatory responses function as evolutionarily conserved protective mechanisms. Acute hypoxia promotes temporary metabolic adaptation to preserve tissue viability, while acute inflammation facilitates clearance of damaged or abnormal cells and restores homeostasis. In tumors, by contrast, hypoxia and inflammation become chronic and unresolved. Persistent activation of these protective signals gradually renders the microenvironment permissive to the sustained adaptation of abnormal cells rather than eliminating them. This transition from clearance to tolerance reshapes cellular metabolism, immune cell behavior, and tissue organization within the tumor microenvironment. As a result, tumor cells increasingly adapt to metabolic stress and evade effective immune surveillance, contributing to malignancy and therapy resistance. Interestingly, some subterranean species, including the naked mole rat and blind mole rat, show natural cancer resistance. They either evolved adaptations counteracting inflammation, or take the immune response to their advantage to prevent cancer. These anti-cancer mechanisms are a result of adaptation to their hypoxic subterranean habitats. In this review, we examine the fundamental features of hypoxia and inflammation in tumors, explore their functional interplay, and discuss how these mechanisms are evaded or harnessed by cancer resistant subterranean mammals. We further propose a simple clearance to resistance framework that links acute protective stress responses, chronic tumor-promoting adaptation, and naturally evolved cancer resistance.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.70401/acrt.2026.0032
- Canonical
- link ↗
- Fetched
- 2026-10-13 MST
Cite this
APA
Xu, Y., & Zhao, Y. (2026). Interplay between hypoxia and inflammation in cancer progression, therapy resistance, and natural cancer resistance. <em>Ageing and Cancer Research & Treatment</em>. https://doi.org/10.70401/acrt.2026.0032
Vancouver
Xu Y, Zhao Y. Interplay between hypoxia and inflammation in cancer progression, therapy resistance, and natural cancer resistance. Ageing and Cancer Research & Treatment. 2026. doi:10.70401/acrt.2026.0032.
BibTeX
@article{yandong2026Interp,
title = {Interplay between hypoxia and inflammation in cancer progression, therapy resistance, and natural cancer resistance},
author = {Yandong Xu and Yang Zhao},
journal = {Ageing and Cancer Research & Treatment},
year = {2026},
doi = {10.70401/acrt.2026.0032},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Annual Review of Pharmacology and Toxicology 2021
Open access · OA
Targeting NRF2 and Its Downstream Processes: Opportunities and Challenges
Biomolecules 2020
Open access · CC-BY
Role of Glutathione in Cancer: From Mechanisms to Therapies
Annual Review of Physiology 2019
Open access · OA
The Acidic Tumor Microenvironment as a Driver of Cancer
Cells 2026
Open access · OA
Potential Roles of Cellular Senescence and Inflammaging in Prostate Cancer: Aging Microenvironment, Immune Remodeling, and Therapeutic Implications.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024
Open access · CC-BY
Hypoxia as a critical player in extracellular vesicles-mediated intercellular communication between tumor cells and their surrounding microenvironment
Signal Transduction and Targeted Therapy 2022
Open access · CC-BY